sun pharma rallies post strong q1 results | here's market expert on earnings of co #1qwithcnbctv18
Published 6 years ago • 1K plays • Length 6:45
Download video MP4
Download video MP3
Similar videos
-
1:46
sun pharma q2fy25 earnings today: high single-digit growth in domestic formulations likely
-
14:30
all about q1 results of pharma & healthcare sector & experts' take on it's fy23 outlook | cnbc-tv18
-
1:53
sp tulsian shares his views on sun pharma stock | cnbctv18
-
2:01
sun pharma to report its q2 results today, here is what expect | trading hour | cnbc-tv18
-
1:47
sun pharma q4 preview: strong growth in specialty biz likely to boost q4 performance | cnbc tv18
-
2:37
sun pharma q1 result tomorrow: key expectations | cnbc tv18
-
1:47
#earningsminute sun pharma registers steady q1
-
8:53
sun pharma's c s muralidharan speaks on the firm's q2fy23 results & fy23 revenue guidance
-
11:17
pfizer ceo albert bourla goes one-on-one with jim cramer
-
22:23
hdfc bank, idfc bank, ril some safe sparklers & value bombs to invest in samvat 2081 | et now
-
4:45
google has a 'big cost advantage' over microsoft azure, says d.a. davidson's gil luria
-
12:45
what are the key stocks & sectors in focus today? | cnbc tv18
-
1:44
sun pharma q2 earnings: net profit at ₹3,040 cr, beats estimates | cnbc tv18
-
5:52
sbi q1 profit seen down 32%. sun pharma in good health?
-
6:16
sun pharma q1fy24 results: net profit in-line, revenue beats estimates | cnbc tv18
-
7:26
growth has been good in the us mkt; expect topline data on psoriatic arthritis by fy25: sun pharma
-
1:51
sun pharma: it systems attack to impact business operations | trading hour | cnbc-tv18
-
7:16
watch cnbc tv18 live | sun pharma beats the street with ₹1,984 crore net profit in q4fy23
-
10:07
sun pharma's cs muralidharan on q4 results, taro acquisition plans & fy24 outlook | halftime report
-
6:39
sun pharma reports a largely in-line set of q4 numbers; us sales come in at $430 m | cnbc tv18
-
0:32
d-street chatter | coforge, anant raj & sun pharma | n18s | cnbc tv18
-
4:16
us did well on account of specialty biz doing well, working on halol, mohali remediation: sun pharma
Clip.africa.com - Privacy-policy